A A A Text Size
E-mail E-mail This Page
 

Technology Transfer

Postdoctoral Research Program

Postdoctoral Research Program

Our postdoctoral programs
Read more »

Graduate Student Programs

Graduate Student Programs

Our graduate student programs
Read more »

The Office of Corporate Alliances (OCA) supports the mission of Fox Chase Cancer Center to accelerate the integration of emerging technologies into team-based science to reduce the burden of cancer in all individuals by facilitating relationships with industry in order to translate clinical and basic research findings into products and services for the public good.

With annual research expenditures that approximate $100 million, Fox Chase Cancer Center is one of the leading freestanding cancer research and treatments centers in the United States.

Research and Technology Symposium

Tuesday May 20
8:30am – 5:30pm
The Academy of Natural Sciences
1900 Benjamin Franklin Parkway
Philadelphia

During the Symposium, researchers provided an overview of Fox Chase's broad array of nationally competitive basic, translational, and clinical research, including its special programs in cancer prevention, detection and treatment. See slide presentations from the Agenda for the Day.

Research topics presented during the Symposium included:

  • changes in cell signaling that occur as tumors progress to metastasis and drug resistance;
  • exploitation of engineered antibody fragments to detect and treat solid tumors;
  • characterization of the genetic changes in cancer cells
  • the biological importance of Rho proteins signaling pathways
  • and more. See a complete list of the research topics discussed.

Along with the research projects mentioned below, a poster session during the lunch hour displayed technologies (e.g., molecular diagnostics, therapeutics, vaccines, devices, and research tools) available for licensing.

For more information, contact the Fox Chase Office of Corporate Alliances.